Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate

Elevated serum phosphate levels as a consequence of chronic kidney disease (CKD) contribute to the increased cardiovascular risk observed in dialysis patients. Protein restriction and dialysis fail to adequately prevent hyperphosphatemia, and in general treatment with oral phosphate binding agents i...

Descripción completa

Detalles Bibliográficos
Autores principales: Persy, Veerle P, Behets, Geert J, De Broe, Marc E, D’Haese, Patrick C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108761/
https://www.ncbi.nlm.nih.gov/pubmed/21694915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108761/
https://www.ncbi.nlm.nih.gov/pubmed/21694915

Ejemplares similares